Editas Medicine (EDIT) Net Margin (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 110,574.00 |
| Jun 30, 2025 | 18,566.00 |
| Mar 31, 2025 | -147,605.00 |
| Dec 31, 2024 | 10.17 Mn |
| Sep 30, 2024 | -8.87 Mn |
| Jun 30, 2024 | -771,988.00 |
| Mar 31, 2024 | -542,727.00 |
| Dec 31, 2023 | 81,228.00 |
| Sep 30, 2023 | 55,164.00 |
| Jun 30, 2023 | -91,363.00 |
| Mar 31, 2023 | 44,753.00 |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | -13.18 Mn |
| Jun 30, 2022 | -10,129.00 |
| Mar 31, 2022 | -41,029.00 |
| Dec 31, 2021 | 29,866.00 |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | -1.37 Mn |
| Mar 31, 2021 | -32,587.00 |
| Dec 31, 2020 | -55,977.00 |
| Sep 30, 2020 | 23,174.00 |
| Jun 30, 2020 | 43,987.00 |
| Mar 31, 2020 | -35,169.00 |
| Dec 31, 2019 | 54,858.00 |
| Sep 30, 2019 | 59,399.00 |
| Jun 30, 2019 | -3,636.00 |
| Mar 31, 2019 | -100,423.00 |
| Dec 31, 2018 | -30,449.00 |
| Sep 30, 2018 | 42,032.00 |
| Jun 30, 2018 | 26,258.00 |
| Mar 31, 2018 | 19,903.00 |
| Dec 31, 2017 | -56,347.00 |
| Sep 30, 2017 | 43,028.00 |
| Jun 30, 2017 | 370,598.00 |
| Mar 31, 2017 | -17,482.00 |
| Dec 31, 2016 | -219,982.00 |
| Sep 30, 2016 | -162,299.00 |
| Jun 30, 2016 | 164,814.00 |
| Mar 31, 2016 | -60,261.00 |
| Dec 31, 2015 | -48,683.00 |
| Sep 30, 2015 | 2.74 Mn |